HomeAI · summaries
Storia in 2 fonti
Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M
In a series of moves by Switzerland-headquartered CDMOs this week, manufacturing powerhouse Lonza is doubling down on its US footprint, while crosstown rival CordenPharma is drafting expansion plan | Lonza's plans for a new spray-drying facility in Bend, Oregon, affirm the company's commitment both to high-margin medicines and the U.S. At the same time, fellow Swiss CDMO CordenPharma is also making expansion moves, albeit closer to home.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build
Spying a “golden decade” beyond the branded drug industry’s looming patent cliff, Sandoz is making big bets on its biosimilar capabilities in the coming years. | Spying a “golden…
- ·
swissinfo.ch
Swiss pharma firm Lonza to build new factory in US
Lonza plans a new factory in Bend, Oregon to expand US spray-drying capacity for complex drug formulations.
